Comparison of Pathway Referrals for Liver Fibrosis Risk Stratification Performed in Diabetology and Nutrition Clinics

References

• Younossi ZM, Henry L. Fatty liver through the ages: nonalcoholic steatohepatitis. Endocr Pract. 2022;28(2):204–213. doi:10.1016/j.eprac.2021.12.010
   PubMed Web of Science ®Google Scholar
• Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13(4):643–54 e1–e9; quiz e39–e40. doi:10.1016/j.cgh.2014.04.014
   Web of Science ®Google Scholar
• Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–285. doi:10.1111/j.1365-2036.2011.04724.x
   PubMed Web of Science ®Google Scholar
• Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 2003;98(9):2042–2047. doi:10.1111/j.1572-0241.2003.07659.x
   PubMed Web of Science ®Google Scholar
• Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389–97 e10. doi:10.1053/j.gastro.2015.04.043
   PubMed Web of Science ®Google Scholar
• Ekstedt M Hagstrom H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61 5 :1547–54. doi:10.1002/hep.27368.
   PubMed Web of Science ®Google Scholar
• Loomba R, Chalasani N. The hierarchical model of NAFLD: prognostic significance of histologic features in NASH. Gastroenterology. 2015;149(2):278–281. doi:10.1053/j.gastro.2015.06.016
   PubMed Web of Science ®Google Scholar
• Simon TG, Roelstraete B, Hagstrom H, Sundstrom J, Ludvigsson JF. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2022;71(9):1867–1875. doi:10.1136/gutjnl-2021-325724
   PubMed Web of Science ®Google Scholar
• Kanwal F, Shubrook JH, Younossi Z, et al. Preparing for the NASH epidemic: a call to action. Gastroenterology. 2021;161(3):1030–1042 e8. doi:10.1053/j.gastro.2021.04.074
   PubMed Web of Science ®Google Scholar
• Kanwal F, Shubrook JH, Adams LA, et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161(5):1657–1669. doi:10.1053/j.gastro.2021.07.049
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address eee, Clinical Practice Guideline P, Chair, representative EGB, Panel M. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021;75(3):659–689. doi:10.1016/j.jhep.2021.05.025
   PubMed Web of Science ®Google Scholar
• Cusi K, Isaacs S, Barb D, et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022;28(5):528–562. doi:10.1016/j.eprac.2022.03.010
   PubMed Web of Science ®Google Scholar
• Draznin B, Aroda VR, Bakris G, et al.; American Diabetes Association Professional Practice C, American Diabetes Association Professional Practice C. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S46–S59. doi:10.2337/dc22-S004
   PubMedGoogle Scholar
• European Association for the Study of the Liver. Electronic address eee, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–1402. doi:10.1016/j.jhep.2015.11.004
   PubMed Web of Science ®Google Scholar
• Abeysekera KWM, Macpherson I, Glyn-Owen K, et al. Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review. Lancet Gastroenterol Hepatol. 2022;7(8):770–780. doi:10.1016/S2468-1253(22)00020-6
   PubMed Web of Science ®Google Scholar
• Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48(5):835–847. doi:10.1016/j.jhep.2008.02.008
   PubMed Web of Science ®Google Scholar
• Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–854. doi:10.1002/hep.21496
   PubMed Web of Science ®Google Scholar
• Shaheen AA, Riazi K, Medellin A, et al. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study. CMAJ Open. 2020;8(2):E370–E376. doi:10.9778/cmajo.20200009
   PubMedGoogle Scholar
• Srivastava A, Gailer R, Tanwar S, et al. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. J Hepatol. 2019;71(2):371–378. doi:10.1016/j.jhep.2019.03.033
   PubMed Web of Science ®Google Scholar
• Alexander M, Loomis AK, Fairburn-Beech J, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16(1):130. doi:10.1186/s12916-018-1103-x
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Anstee QM, Hagstrom H, et al. Defining comprehensive models of care for NAFLD. Nat Rev Gastroenterol Hepatol. 2021;18(10):717–729. doi:10.1038/s41575-021-00477-7
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Mark HE, Anstee QM, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19(1):60–78. doi:10.1038/s41575-021-00523-4
   PubMed Web of Science ®Google Scholar
• Anstee QM, Hallsworth K, Lynch N, et al. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. JHEP Rep. 2022;4(1):100411. doi:10.1016/j.jhepr.2021.100411
   PubMedGoogle Scholar
• Cazac GD, Lacatusu CM, Mihai C, Grigorescu ED, Onofriescu A, Mihai BM. Ultrasound-based hepatic elastography in non-alcoholic fatty liver disease: focus on patients with type 2 diabetes. Biomedicines. 2022;10(10):2375. doi:10.3390/biomedicines10102375
   PubMed Web of Science ®Google Scholar
• Ciardullo S, Muraca E, Perra S, et al. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. BMJ Open Diabetes Res Care. 2020;8(1):e000904. doi:10.1136/bmjdrc-2019-000904
   PubMed Web of Science ®Google Scholar
• Ciardullo S, Ronchetti C, Muraca E, et al. Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD. J Endocrinol Invest. 2020;43(7):1019–1026. doi:10.1007/s40618-020-01188-7
   PubMed Web of Science ®Google Scholar
• Boursier J, Hagstrom H, Ekstedt M, et al. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events. J Hepatol. 2022;76(5):1013–1020. doi:10.1016/j.jhep.2021.12.031
   PubMed Web of Science ®Google Scholar
• Gracen L, Hayward KL, Irvine KM, Valery PC, Powell EE. Low accuracy of FIB-4 test to identify people with diabetes at low risk of advanced fibrosis. J Hepatol. 2022;77(4):1219–1221. doi:10.1016/j.jhep.2022.06.016
   PubMed Web of Science ®Google Scholar
• Gracen L, Hayward KL, Aikebuse M, et al. Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes. BMC Health Serv Res. 2022;22(1):487. doi:10.1186/s12913-022-07808-7
   PubMed Web of Science ®Google Scholar